Georgia § 16-13-24 Establishment of schedules of controlled substances

Georgia Statutes

§ 16-13-24 — Establishment of schedules of controlled substances

Georgia § 16-13-24

Title16

This text of Georgia § 16-13-24 (Establishment of schedules of controlled substances) is published on Counsel Stack Legal Research, covering Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

O.C.G.A. § 16-13-24 (2026).

Text

(a)There are established five schedules of controlled substances, to be known as Schedules I, II, III, IV, and V. The schedules shall consist of the substances listed in Code Sections 16-13-25 through 16-13-29 . The schedules so established shall be updated and republished by the State Board of Pharmacy on an annual basis.

(b)Except in the case of an immediate precursor, a drug or other substance may not be placed in any schedule unless the findings required for such schedule are made with respect to the drug or other substance. The findings for each of the schedules are as follows:

(1)Schedule I:

(A)The drug or other substance has a high potential for abuse;

(B)The drug or other substance has no currently accepted medical use in treatment in the United States; and (C) There is a lack

Free access — add to your briefcase to read the full text and ask questions with AI

(a) There are established five schedules of controlled substances, to be known as Schedules I, II, III, IV, and V. The schedules shall consist of the substances listed in Code Sections 16-13-25 through 16-13-29 . The schedules so established shall be updated and republished by the State Board of Pharmacy on an annual basis. (b) Except in the case of an immediate precursor, a drug or other substance may not be placed in any schedule unless the findings required for such schedule are made with respect to the drug or other substance. The findings for each of the schedules are as follows: (1) Schedule I: (A) The drug or other substance has a high potential for abuse; (B) The drug or other substance has no currently accepted medical use in treatment in the United States; and (C) There is a lack of accepted safety for use of the drug or other substance under medical supervision. (2) Schedule II: (A) The drug or other substance has a high potential for abuse; (B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions; and (C) Abuse of the drug or other substance may lead to severe psychological or physical dependence. (3) Schedule III: (A) The drug or other substance has a potential for abuse less than the drugs or other substances in Schedules I and II; (B) The drug or other substance has a currently accepted medical use in treatment in the United States; and (C) Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence. (4) Schedule IV: (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in Schedule III; (B) The drug or other substance has a currently accepted medical use in treatment in the United States; and (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in Schedule III. (5) Schedule V: (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in Schedule IV; (B) The drug or other substance has a currently accepted medical use in treatment in the United States; and (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in Schedule IV.